Court throws out Merck Sharp & Dohme’s Januvia patent extension

Australian Government Solicitor 2021-08-12 2:29 pm By Miklos Bolza | Sydney

Please login to bookmark

The Federal Court has dealt US drug giant Merck Sharp & Dohme a devastating blow, overturning an “untenable” patent term extension which would have protected the monopoly of its multibillion-dollar Januvia and Janumet diabetes drugs beyond July 2o22.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au